UK firm GSK to pay $2.2bn over Zantac cancer claims

UK firm GSK to pay $2.2bn over Zantac cancer claims

 BBC News

​The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants. The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants. 

Leave a Reply

Your email address will not be published. Required fields are marked *